FDAnews
www.fdanews.com/articles/96357-abbott-rsquo-s-aluvia-tablet-approved-in-19-african-countries

Abbott’s Aluvia Tablet Approved in 19 African Countries

July 26, 2007

Abbott announced that it has received approval from 19 African countries for Aluvia, an HIV treatment.

According to Abbott, Aluvia (lopinavir/ritonavir) was approved in the following African countries: Angola, Benin, Botswana, Burundi, Comoros, Djibouti, Democratic Republic of Congo, Ghana, Kenya, Libya, Malawi, Mauritius, Namibia, Rwanda, Senegal, Sierra Leone, Tanzania, Uganda and Zambia.

The company said it has worked to register the tablet with total filings in 137 countries and approvals in 90. It added that in an effort to make Aluvia available in developing countries, it is placing an emphasis on accelerated filings.

The company said it will maintain its current lopinavir/ritonavir price of $500 per patient annually in Africa and the least developed countries for the new formulation.